NCT00038896已完成3 期
A Double-blind, Placebo-controlled, Parallel-group, Flexible-dose Study of Venlafaxine Extended-release Capsules in Adult Outpatients With Panic Disorder
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 343 人开始时间: 2001年4月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 343
研究概览
简要总结
The primary objective of this study is to determine the efficacy, safety, and tolerability of a flexible dose of venlafaxine extended-release (ER) capsules administered for 10 weeks in the treatment of adult outpatients with panic disorder (PD) in a placebo-controlled phase III study.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •A male or female outpatient
- •Be at least 18 years of age and legal age of consent
- •Meet DSM-IV criteria for PD (with or without agoraphobia) for at least 3 months before study day 1
排除标准
- •Treatment with venlafaxine (IR or ER) within 6 months of study day 1
- •Known hypersensitivity to venlafaxine (IR or ER) or related compounds
- •History or presence of any clinically important hepatic, renal, or other medical disease that might compromise the study or be detrimental to the patient (eg, clinically important cardiac arrhythmia, unstable diabetes, carcinoma [except basal cell epithelioma], uncontrolled hypertension)
研究者
相似试验
已完成
3 期
Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety DisorderBipolar DisorderAnxiety DisorderNCT00277654Lindner Center of HOPE111
进行中(未招募)
1 期
Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back PainChronic Low-back PainDegenerative Disc DiseaseNCT06053242Creative Medical Technology Holdings Inc45
已完成
1 期
Influenza Vaccine Challenge Study in Healthy SubjectsInfluenzaNCT01226758PepTcell Limited32
已完成
1 期
A Study for Moderate Osteoarthritis of the KneeOsteoarthritisNCT01478997Vedic Lifesciences Pvt. Ltd.76
Unknown
1 期
Tolerability, Safety and Pharmacokinetic Study Of Mianhuahua Flavonoids Tablets in Healthy Adult SubjectsHealthyNCT02622230Xinjiang Uygur Pharmaceutical Co., Ltd.60
